Digitisation | November 14, 2023
Bayer and Recursion focus research collaboration on Oncology
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Lack of technology transfer stands out as a formidable barrier
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Investment is additive to KKR’s existing health care growth strategy
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Subscribe To Our Newsletter & Stay Updated
